Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link



Dow Jones Industrial Average



) is trading up 71 points (+0.4%) at 16,428 as of Thursday, Dec 26, 2013, 11:34 a.m. ET. During this time, 66.6 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 373.3 million. The NYSE advances/declines ratio sits at 1,679 issues advancing vs. 1,241 declining with 183 unchanged.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be

United Technologies


TheStreet Recommends


), which is sporting a $1.12 gain (+1%) bringing the stock to $112.59. This single gain is lifting the Dow Jones Industrial Average by 8.48 points or roughly accounting for 11.9% of the Dow's overall gain. Volume for United Technologies currently sits at 832,300 shares traded vs. an average daily trading volume of 2.9 million shares.

United Technologies has a market cap of $102.28 billion and is part of the industrial goods sector and industrial industry. Shares are up 35.9% year to date as of Tuesday's close. The stock's dividend yield sits at 2.1%.

United Technologies Corporation provides technology products and services to the building systems and aerospace industries worldwide.

TheStreet Ratings rates United Technologies as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more